NFA
VYGR icon

Nationwide Fund Advisors’s Voyager Therapeutics VYGR Stock Holding History

Nationwide Fund Advisors’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-19,779
Closed -$407K – 2069
2017
Q3 		$407K Buy
19,779
+8,884
+82% +$100K ﹤0.01% 2285
2017
Q2 		$98K Buy
10,895
+4,400
+68% +$44.3K ﹤0.01% 2905
2017
Q1 		$86K Sell
6,495
-966
-13% -$11.7K ﹤0.01% 2882
2016
Q4 		$95K Hold
7,461
– – ﹤0.01% 2888
2016
Q3 		$90K Hold
7,461
– – ﹤0.01% 2924
2016
Q2 		$82K Buy
7,461
+4,088
+121% +$50K ﹤0.01% 2985
2016
Q1 		$29K Hold
3,373
– – ﹤0.01% 3068
2015
Q4 		$74K Buy
+3,373
New +$77.7K ﹤0.01% 2923

Other funds holding VYGR

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Nationwide Fund Advisors's VYGR Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Voyager Therapeutics (VYGR) in Q4 2017, closing a stake of 19,779 shares — an estimated $407K sold.

Nationwide Fund Advisors first reported a position in VYGR in Q4 2015 and held it in 8 quarters. The position peaked at $407K in Q3 2017. 98 funds tracked by Wall St. Rank hold VYGR as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Voyager Therapeutics position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 19,779 Voyager Therapeutics shares in Q4 2017, an estimated $407K.
  • Nationwide Fund Advisors first reported a position in Voyager Therapeutics in Q4 2015 and held it in 8 quarters.
  • Nationwide Fund Advisors's Voyager Therapeutics position peaked at $407K in Q3 2017.
  • 98 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.